• About
• Latest Posts
• Latest Blog Posts
• Boards Posted On
• Boards Moderating

bwolfy2002

Send Private Message

Follow Member

Block Messages

Ignore This User

Displaying 751-800 of 820 result(s).

Board Name	Posts By bwolfy2002	Post Created
CYDY CytoDyn Inc	Still at .32 resistance... lol	12/04/2019 9:18:46 AM
CYDY CytoDyn Inc	Looks like he sold just under 5mm s	12/04/2019 8:54:12 AM
CYDY CytoDyn Inc	https://s3.amazonaws.com/content.s	12/04/2019 8:37:32 AM
CYDY CytoDyn Inc	There’s our seller.... Pestell (1)	12/04/2019 8:36:44 AM
CYDY CytoDyn Inc	But can’t conditional deals be ma (1)	12/03/2019 8:30:11 PM
CYDY CytoDyn Inc	Yes I noticed that he didn’t spea	12/03/2019 2:21:19 PM
CYDY CytoDyn Inc	Can anyone elaborate further on 90%	12/03/2019 2:00:39 PM
GNBTQ Generex Biotechnology Corp.	This is the $40mm-$70mm question. W	12/03/2019 12:17:23 PM
GNBTQ Generex Biotechnology Corp.	From my understanding it’s just t	12/03/2019 9:19:36 AM
CYDY CytoDyn Inc	I see, the last PR that didn’t gi	12/03/2019 8:19:27 AM
CYDY CytoDyn Inc	No mention of tumor reduction, or a	12/03/2019 8:14:21 AM
GNBTQ Generex Biotechnology Corp.	You’re right in saying every shar (1)	12/03/2019 1:02:31 AM
GNBTQ Generex Biotechnology Corp.	Incorrect. If just given to float a (1)	12/02/2019 10:57:52 PM
CYDY CytoDyn Inc	I am not suggesting holding anyone	12/02/2019 8:45:35 PM
CYDY CytoDyn Inc	Correct, but how can anyone project	12/02/2019 8:36:48 PM
GNBTQ Generex Biotechnology Corp.	Further, the more time that passes (2)	12/02/2019 8:32:22 PM
GNBTQ Generex Biotechnology Corp.	Right, I have changed my desired or (2)	12/02/2019 8:27:52 PM
GNBTQ Generex Biotechnology Corp.	I’m inclined to agree. This remov	12/02/2019 7:41:45 PM
CYDY CytoDyn Inc	Which is odd to me given that we ar	12/02/2019 7:35:20 PM
GNBTQ Generex Biotechnology Corp.	In my experience, the SEC does not	12/02/2019 6:03:32 PM
GNBTQ Generex Biotechnology Corp.	Wish Yahoo Finance was correct. Say (1)	12/02/2019 5:22:06 PM
GNBTQ Generex Biotechnology Corp.	I think we need to get 5 days above (1)	12/01/2019 3:14:37 PM
CYDY CytoDyn Inc	If they go it alone, it will be a t	12/01/2019 1:33:34 PM
GNBTQ Generex Biotechnology Corp.	This is much more in my wheelhouse (4)	11/30/2019 8:22:47 PM
GNBTQ Generex Biotechnology Corp.	What is Joe talking about the Q in	11/29/2019 12:48:42 PM
GNBTQ Generex Biotechnology Corp.	Yes, the new dividend has been shel	11/29/2019 12:47:52 PM
GNBTQ Generex Biotechnology Corp.	I too missed the call until about 3	11/29/2019 11:09:38 AM
CYDY CytoDyn Inc	Also true, I am by no means suggest	11/29/2019 9:18:30 AM
CYDY CytoDyn Inc	This is a fantastic point about bur	11/29/2019 8:29:52 AM
GNBTQ Generex Biotechnology Corp.	Should have paid it on 10/29.	11/27/2019 4:44:14 PM
GNBTQ Generex Biotechnology Corp.	What a $h1t show... I have horrid t (1)	11/27/2019 4:39:15 PM
GNBTQ Generex Biotechnology Corp.	Are they done? They are already bus	11/27/2019 11:05:25 AM
GNBTQ Generex Biotechnology Corp.	Not to mention their selling may ha (1)	11/27/2019 10:45:32 AM
GNBTQ Generex Biotechnology Corp.	There is logic in that except that	11/26/2019 6:37:21 PM
GNBTQ Generex Biotechnology Corp.	No, I’m on Fidelity, I thought I	11/26/2019 3:56:40 PM
GNBTQ Generex Biotechnology Corp.	Correct, but their agreement which	11/26/2019 2:54:42 PM
GNBTQ Generex Biotechnology Corp.	Extremely. Also sounds time consumi	11/26/2019 2:43:56 PM
GNBTQ Generex Biotechnology Corp.	This wouldn’t make sense because (1)	11/26/2019 2:39:36 PM
GNBTQ Generex Biotechnology Corp.	However the cap structure is affect	11/25/2019 7:13:26 PM
GNBTQ Generex Biotechnology Corp.	My quotes have been wonky all day i (1)	11/25/2019 12:02:57 PM
GNBTQ Generex Biotechnology Corp.	Hmm, no certainty, but I would thin (1)	11/23/2019 7:58:16 PM
GNBTQ Generex Biotechnology Corp.	That’s possible.	11/22/2019 1:06:27 PM
GNBTQ Generex Biotechnology Corp.	Where are you going with this?	11/22/2019 8:15:11 AM
CYDY CytoDyn Inc	The Cleveland Clinic is a non-profi (1)	11/21/2019 11:01:09 AM
CYDY CytoDyn Inc	I approve (1)	11/21/2019 9:51:11 AM
CYDY CytoDyn Inc	Sure, depends on your drug(s), how	11/20/2019 5:18:58 PM
CYDY CytoDyn Inc	I fear “going it alone”. I have (1)	11/20/2019 2:19:13 PM
GNBTQ Generex Biotechnology Corp.	It is curious, and I can only repea	11/19/2019 5:13:01 PM
GNBTQ Generex Biotechnology Corp.	Not only did they say they weren’ (1)	11/19/2019 4:20:58 PM
CYDY CytoDyn Inc	Are we do assume Dr. Sacha’s abst	11/16/2019 10:45:35 AM

• Next >

56092215609161560913256091315608909560854356084995608321560788856077515607742560754456075025607441560743956074375607436560741756074125607376560735356062875606260560595556055275605525560541456052895605234560465556046515604198560417156036235603497560339856033865603377560233156019235600871560009055995675598670559851555979565597763559672555966695593879

Recent Articles

• Meta Boosts AI Team with OpenAI Expert Shengjia Zhao
• Bitget Expands Its Influence in Southeast Asia's Crypto Scene
• Tesla's Upcoming Shareholder Proposals on xAI Investment Strategies
• Reckitt Benckiser Investors: Join the Class Action Today!
• Exploring China's Economic Resilience Amid Global Challenges
• Investors Alert: Join Class Action Against Reckitt Benckiser
• Investigation Opportunities for Hims & Hers Health Shareholders
• Investors Alert: Lawsuit Against Tempus AI Affects Shareholders
• Investors Urged to Claim Losses in Neogen Corporation Lawsuit
• Reinforcing Trilateral Environmental Collaboration in North America
• Mercury Insurance to Extend Homeowners Coverage for Californians
• Klotho Neurosciences, Inc. Innovates for Healthy Aging and Longevity
• Flywire Corporation Faces Class Action: All You Need to Know
• Understanding the Easterly ROCMuni Fund Class Action: Key Insights
• Arnold & Itkin Takes Legal Action Against Chevron Over Explosion
• Paul Mueller Company Revamps Earnings Report for 2025
• Westbridge Renewable Energy's Strategic Share Consolidation Details
• Investigation into Data Breach Claims for Tea App Users
• Traction Uranium Secures Funding of Up to C$833,400 for Expansion
• Diginex Moves Forward with Bonus Shares and Shareholder Decisions
• Faircourt Asset Management Details July Fund Distribution
• Unveiling Investigations into Crocs, Inc. Stockholder Rights
• Essential Guide to Enjoying Summer with CASEKOO's Magic Stand
• Nutex Health Faces Scrutiny After Blue Orca Capital Report
• Caribou Biosciences Explores Legal Options for Shareholders
• Chipotle Faces Legal Scrutiny: What Investors Should Know
• The Growth of $100 in Danaher Corporation Over the Years
• Unveiling The Stunning Growth of Tesla's Stock Value
• Black Pearl Equities Initiates Tender Offer for Regional Health Shares
• ISS Endorses Merger Between Regional Health Properties and SunLink
• Grupo Bafar Reports Strong Second Quarter Performance in 2025
• Black Pearl Equities Expands Investment Opportunities for RHEP Shares
• Investor Alert: Atkore Inc. Under Investigation for Misconduct
• Legal Investigation Announced for Acadia Healthcare Stockholders
• Transforming $1000 in RTX into a Profitable Investment Journey
• Investors Have Chance to Participate in Luminar Lawsuit
• Exploring Devon Energy's Stock Growth Over Five Years
• Lombard Street Capital and Lithium Africa's Strategic Merger
• A Look at Reinsurance Group's Remarkable Growth Over 5 Years
• Understanding Investor Rights Amid Semler Scientific Disputes
• Insights into Tungray Technologies Inc and Investor Rights
• Critical Legal Actions Impacting Fiserv Investors This Year
• VineBrook Homes Trust Cancels Annual Stockholder Meeting
• Empowering REALTORS with Innovative Tools for Success
• Significant Growth of Laureate Education Stock Over Five Years
• ChoiceCash Launches Online Auto Equity Loans in Hawaii
• Investors May Drive Securities Fraud Class Action for Mutual Funds
• Oscar Health: Navigating the Storm in Health Insurance Market
• Discovering Hidden Gems: Stocks Beyond the S&P 500 Limelight
• ServiceNow Set to Disrupt with Its AI-Fueled Growth